Skip to main content
Erschienen in:

09.11.2022 | Menopause

Medikamentöse Therapie der Endometriose – ein Update

verfasst von: Prof. Dr. med. Thomas Römer

Erschienen in: Journal für Gynäkologische Endokrinologie/Schweiz | Ausgabe 4/2022

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die Endometriose ist eine der häufigsten gynäkologischen Erkrankungen. In den meisten Fällen ist heute eine klinische Diagnostik möglich, sodass zunächst eine primäre medikamentöse Therapie erfolgen kann, wenn keine absoluten Operationsindikationen bestehen. Da es sich um eine chronische Erkrankung handelt, sind medikamentöse Langzeitbehandlungen sowohl in der primären Therapie als auch in der adjuvanten Therapie nach Operationen zu bevorzugen. Kombinierte orale Kontrazeptiva haben einen positiven Effekt auf die Dysmenorrhö, aber meist nicht auf die anderen Symptome. Des Weiteren sind hier entsprechende Kontraindikationen zu beachten und es ist mit einer potenziellen Progression der Erkrankung unter der Anwendung von kombinierten oralen Kontrazeptiva zu rechnen. Gestagene haben deshalb einen sehr hohen Stellenwert, da sie in der Langzeittherapie bei einem günstigen Nebenwirkungsprofil sehr effektiv sind. Dienogest hat hier gegenüber anderen Gestagenen klinisch relevante Vorteile. GnRH-Analoga und in Zukunft auch GnRH-Antagonisten stellen eine Second-line-Therapieoption dar. Für die Therapie der Adenomyosis ist die Anwendung eines Levonorgestrel-Intrauterinpessars mit 52 mg zu favorisieren. Der Stellenwert der medikamentösen Endometriosetherapie hat in den letzten Jahren deutlich zugenommen.
Literatur
1.
Zurück zum Zitat Agarwal SK, Chapron C, Giudice LC, Laufer MR, Leyland N, Missmer SA et al (2019) Clinical diagnosis of endometriosis: a call to action. Am J Obstet Gynecol 220:354.e1–e12CrossRef Agarwal SK, Chapron C, Giudice LC, Laufer MR, Leyland N, Missmer SA et al (2019) Clinical diagnosis of endometriosis: a call to action. Am J Obstet Gynecol 220:354.e1–e12CrossRef
2.
Zurück zum Zitat AWMF Leitlinie (2020) Diagnostik und Therapie der Endometriose (Nr. 015/045) AWMF Leitlinie (2020) Diagnostik und Therapie der Endometriose (Nr. 015/045)
3.
Zurück zum Zitat Bahamondes L, Petta CA, Fernandes A, Monteiro I (2007) Use of the levonorgestrel-releasing intrauterine system in women with endometriosis, chronic pelvic pain and dysmenorrhea. Contraception 75:134–139CrossRef Bahamondes L, Petta CA, Fernandes A, Monteiro I (2007) Use of the levonorgestrel-releasing intrauterine system in women with endometriosis, chronic pelvic pain and dysmenorrhea. Contraception 75:134–139CrossRef
4.
Zurück zum Zitat Becker C et al (2022) ESHRE guideline: endometriosis. Hum Reprod Open 26(2):hoac9CrossRef Becker C et al (2022) ESHRE guideline: endometriosis. Hum Reprod Open 26(2):hoac9CrossRef
5.
Zurück zum Zitat Bragheto AM, Caserta N, Bahamondes L, Petta CA (2007) Effectiveness of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis diagnosed and monitored by magnetic resonance imaging. Contraception 76:195–199CrossRef Bragheto AM, Caserta N, Bahamondes L, Petta CA (2007) Effectiveness of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis diagnosed and monitored by magnetic resonance imaging. Contraception 76:195–199CrossRef
6.
Zurück zum Zitat Brown J, Pan A, Hart RJ (2010) Gonadotrophin-releasing hormone analogues for pain associated with endometriosis. Cochrane Database Syst Rev 12:CD8475 Brown J, Pan A, Hart RJ (2010) Gonadotrophin-releasing hormone analogues for pain associated with endometriosis. Cochrane Database Syst Rev 12:CD8475
7.
Zurück zum Zitat Brown J, Kives S, Akhtar M (2012) Progestagens and anti-progestagens for pain associated with endometriosis. Cochrane Database Syst Rev 3:CD2122 Brown J, Kives S, Akhtar M (2012) Progestagens and anti-progestagens for pain associated with endometriosis. Cochrane Database Syst Rev 3:CD2122
8.
Zurück zum Zitat Brown J, Crawford TJ, Datta S, Prentice A (2018) Oral contraceptives for pain associated with endometriosis. Cochrane Database Syst Rev 5:CD1019 Brown J, Crawford TJ, Datta S, Prentice A (2018) Oral contraceptives for pain associated with endometriosis. Cochrane Database Syst Rev 5:CD1019
9.
Zurück zum Zitat Caruso S, Iraci M, Cianci S, Vitale SG, Fava V, Cianci A (2019) Effects of long-term treatment with dienogest on the quality of life and sexual function of women affected by endometriosis-associated pelvic pain. J Pain Res 12:2371–2378CrossRef Caruso S, Iraci M, Cianci S, Vitale SG, Fava V, Cianci A (2019) Effects of long-term treatment with dienogest on the quality of life and sexual function of women affected by endometriosis-associated pelvic pain. J Pain Res 12:2371–2378CrossRef
10.
Zurück zum Zitat Casper RF (2017) Progestin-only pills may be a better first-line treatment for endometriosis than combined estrogen-progestin contraceptive pills. Fertil Steril 107:533–536CrossRef Casper RF (2017) Progestin-only pills may be a better first-line treatment for endometriosis than combined estrogen-progestin contraceptive pills. Fertil Steril 107:533–536CrossRef
11.
Zurück zum Zitat Chapron C, Souza C, Borghese B, Lafay-Pillet MC, Santulli P, Bijaou G et al (2011) Oral contraceptives and endometriosis: the past use of oral contraceptives for treating severe primary dysmenorrhea is associated with endometriosis, especially deep infiltrating endometriosis. Hum Reprod 26:2028–2035CrossRef Chapron C, Souza C, Borghese B, Lafay-Pillet MC, Santulli P, Bijaou G et al (2011) Oral contraceptives and endometriosis: the past use of oral contraceptives for treating severe primary dysmenorrhea is associated with endometriosis, especially deep infiltrating endometriosis. Hum Reprod 26:2028–2035CrossRef
12.
Zurück zum Zitat Duffy JM, Arambage K, Correa FJ, Olive D, Farquhar C, Garry R, Barlow DH, Jacobson TZ (2014) Laparoscopic surgery for endometriosis. Cochrane Database Syst Rev 3:CD11031 Duffy JM, Arambage K, Correa FJ, Olive D, Farquhar C, Garry R, Barlow DH, Jacobson TZ (2014) Laparoscopic surgery for endometriosis. Cochrane Database Syst Rev 3:CD11031
13.
Zurück zum Zitat Dunselman GA, Vermeulen N, Becker C, Calhaz-Jorge C, D’Hooghe T, De Bie B et al (2014) ESHRE guideline: management of women with endometriosis. Hum Reprod 29:400–412CrossRef Dunselman GA, Vermeulen N, Becker C, Calhaz-Jorge C, D’Hooghe T, De Bie B et al (2014) ESHRE guideline: management of women with endometriosis. Hum Reprod 29:400–412CrossRef
14.
Zurück zum Zitat Ebert AD (2018) Daily vaginal application of dienogest (Visanne®) for 3 months in symptomatic deeply infiltrating rectovaginal endometriosis: a possible new treament approach? Case Rep Obstet Gynecol 2018:8175870 Ebert AD (2018) Daily vaginal application of dienogest (Visanne®) for 3 months in symptomatic deeply infiltrating rectovaginal endometriosis: a possible new treament approach? Case Rep Obstet Gynecol 2018:8175870
15.
Zurück zum Zitat Ebert AD, Dong L, Merz M, Kirsch B, Francuski M, Böttcher B, Roman H, Suvitie P, Hlavackova O, Gude K, Seitz C (2017) Dienogest 2 mg daily in the treatment of adolescents with clinically suspected endometriosis: the VISanne study to assess safety in ADOlescents. J Pediatr Adolesc Gynecol 30:560–567CrossRef Ebert AD, Dong L, Merz M, Kirsch B, Francuski M, Böttcher B, Roman H, Suvitie P, Hlavackova O, Gude K, Seitz C (2017) Dienogest 2 mg daily in the treatment of adolescents with clinically suspected endometriosis: the VISanne study to assess safety in ADOlescents. J Pediatr Adolesc Gynecol 30:560–567CrossRef
16.
Zurück zum Zitat Ferrero S, Gillott DJ, Venturini PL, Remorgida V (2011) Use of aromatase inhibitors to treat endometriosis-related pain symptoms: a systematic review. Reprod Biol Endocrinol 9:89CrossRef Ferrero S, Gillott DJ, Venturini PL, Remorgida V (2011) Use of aromatase inhibitors to treat endometriosis-related pain symptoms: a systematic review. Reprod Biol Endocrinol 9:89CrossRef
17.
Zurück zum Zitat Ferrero S, Camerini G, Seracchioli R, Ragni N, Venturini PL, Remorgiada V (2009) Letrozole combined with norethisterone acetate compared with norethisterone acetate alone in the treatment of pain symptoms caused by endometriosis. Hum Reprod 24:3033–3041CrossRef Ferrero S, Camerini G, Seracchioli R, Ragni N, Venturini PL, Remorgiada V (2009) Letrozole combined with norethisterone acetate compared with norethisterone acetate alone in the treatment of pain symptoms caused by endometriosis. Hum Reprod 24:3033–3041CrossRef
18.
Zurück zum Zitat Gupta D, Hull ML, Fraser I, Miller L, Bossuyt PMM, Johnson N, Nisenblat V (2016) Endometrial biomarkers for the non-invasive diagnosis of endometriosis. Cochrane Database Syst Rev 5:CD12179 Gupta D, Hull ML, Fraser I, Miller L, Bossuyt PMM, Johnson N, Nisenblat V (2016) Endometrial biomarkers for the non-invasive diagnosis of endometriosis. Cochrane Database Syst Rev 5:CD12179
19.
Zurück zum Zitat Hudelist G, Fritzer N, Thomas A, Niehues C, Oppelt P, Haas D et al (2012) Diagnostic delay for endometriosis in Austria and Germany: causes and possible consequences. Hum Reprod 27:3412–3416CrossRef Hudelist G, Fritzer N, Thomas A, Niehues C, Oppelt P, Haas D et al (2012) Diagnostic delay for endometriosis in Austria and Germany: causes and possible consequences. Hum Reprod 27:3412–3416CrossRef
20.
Zurück zum Zitat Johnson NP, Hummelshoj L, Adamson GD, Keckstein J, Taylor HS, Abrao MS et al (2017) World endometriosis society consensus on the classification of endometriosis. Hum Reprod 32:315–324CrossRef Johnson NP, Hummelshoj L, Adamson GD, Keckstein J, Taylor HS, Abrao MS et al (2017) World endometriosis society consensus on the classification of endometriosis. Hum Reprod 32:315–324CrossRef
21.
Zurück zum Zitat Keckstein J, Saridogan E, Ulrich U, Sillem M, Oppelt P, Schweppe KW et al (2021) The #ENZIAN classification: a comprehensive non-invasive and surgical description system for endometriosis. Acta Obstet Gynecol Scand 100(7):1165–1175CrossRef Keckstein J, Saridogan E, Ulrich U, Sillem M, Oppelt P, Schweppe KW et al (2021) The #ENZIAN classification: a comprehensive non-invasive and surgical description system for endometriosis. Acta Obstet Gynecol Scand 100(7):1165–1175CrossRef
22.
Zurück zum Zitat Kitawaki J, Kado N, Ishihara H, Koshiba H, Kitaoka Y, Honjo H (2002) Endometriosis: the pathophysiology as an estrogen-dependent disease. J Steroid Biochem Mol Biol 83:149–155CrossRef Kitawaki J, Kado N, Ishihara H, Koshiba H, Kitaoka Y, Honjo H (2002) Endometriosis: the pathophysiology as an estrogen-dependent disease. J Steroid Biochem Mol Biol 83:149–155CrossRef
23.
Zurück zum Zitat Koga K, Takamura M, Fujii T, Osuga Y (2015) Prevention of the recurrence of symptom and lesions after conservative surgery for endometriosis. Fertil Steril 104:793–801CrossRef Koga K, Takamura M, Fujii T, Osuga Y (2015) Prevention of the recurrence of symptom and lesions after conservative surgery for endometriosis. Fertil Steril 104:793–801CrossRef
24.
Zurück zum Zitat Leone Roberti Maggiore U, Remorgida V, Scala C, Tafi E, Venturini PL, Ferrero S (2014) Desogestrel-only contraceptive pill versus sequential contraceptive vaginal ring in the treatment of rectovaginal endometriosis infiltrating the rectum: a prospective open-label comparative study. Acta Obstet Gynecol Scand 93:239–247CrossRef Leone Roberti Maggiore U, Remorgida V, Scala C, Tafi E, Venturini PL, Ferrero S (2014) Desogestrel-only contraceptive pill versus sequential contraceptive vaginal ring in the treatment of rectovaginal endometriosis infiltrating the rectum: a prospective open-label comparative study. Acta Obstet Gynecol Scand 93:239–247CrossRef
25.
Zurück zum Zitat Merlot B, Ploteau S, Abergel A, Rubob C, Hocke C, Canis M, Fritel X, Roman H, Collinet P (2018) Extragenital endometriosis: parietal, thoracic, diaphragmatic and nervous lesions. CNGOF-HAS endometriosis guidelines. Gynecol Obstet Fertil Senol 46:619–325 Merlot B, Ploteau S, Abergel A, Rubob C, Hocke C, Canis M, Fritel X, Roman H, Collinet P (2018) Extragenital endometriosis: parietal, thoracic, diaphragmatic and nervous lesions. CNGOF-HAS endometriosis guidelines. Gynecol Obstet Fertil Senol 46:619–325
26.
Zurück zum Zitat Moen MH, Rees M, Brincat M, Erel T, Gabacciano M, Labrinoudaki I, Schenck-Gustafsson K, Tremollieres F, Vujovic S, Rozenberg S (2010) European menopause and andropausae society. EMAS position statement: managing the menopause in women with a past history of endometriosis. Maturitas 67:94–97CrossRef Moen MH, Rees M, Brincat M, Erel T, Gabacciano M, Labrinoudaki I, Schenck-Gustafsson K, Tremollieres F, Vujovic S, Rozenberg S (2010) European menopause and andropausae society. EMAS position statement: managing the menopause in women with a past history of endometriosis. Maturitas 67:94–97CrossRef
27.
Zurück zum Zitat Morotti M, Sozzi F, Remorgida V, Venturini PL, Ferrero S (2014) Dienogest in women with persistent endometriosis-related pelvic pain during norethisterone acetate treatment. Eur J Obstet Gynecol Reprod Biol 183:188–192CrossRef Morotti M, Sozzi F, Remorgida V, Venturini PL, Ferrero S (2014) Dienogest in women with persistent endometriosis-related pelvic pain during norethisterone acetate treatment. Eur J Obstet Gynecol Reprod Biol 183:188–192CrossRef
28.
Zurück zum Zitat Murji A, Biberoglu K, Leng J et al (2020) Use of dienogest in endometriosis: a narrative literature review and expert commentary. Curr Med Res Opin 36(5):895–907CrossRef Murji A, Biberoglu K, Leng J et al (2020) Use of dienogest in endometriosis: a narrative literature review and expert commentary. Curr Med Res Opin 36(5):895–907CrossRef
29.
Zurück zum Zitat Muzzi L, Di Tucci C, Achilli C, Di Donato V, Musella A, Palaia I, Panici PB (2016) Continuous versus cyclic oral contraceptives after laparoscopic excision of ovarian endometriomas: a systematic review an meta-analysis. Am J Obstet Gynecol 214:202–2011 Muzzi L, Di Tucci C, Achilli C, Di Donato V, Musella A, Palaia I, Panici PB (2016) Continuous versus cyclic oral contraceptives after laparoscopic excision of ovarian endometriomas: a systematic review an meta-analysis. Am J Obstet Gynecol 214:202–2011
30.
Zurück zum Zitat Oh ST (2015) The comparison between 2 mg dienogest and high-dose medroxyprogesaterone acetate on oral treatment of endometriosis. J Minim Invasive Gynecol 22:S170CrossRef Oh ST (2015) The comparison between 2 mg dienogest and high-dose medroxyprogesaterone acetate on oral treatment of endometriosis. J Minim Invasive Gynecol 22:S170CrossRef
31.
Zurück zum Zitat Osuga Y, Fujimoto-Okabe H, Hagino A (2017) Evaluation of the efficacy and safety of dienogest in the treatment of painful symptoms in patients with adenomyosis: a randomized, double-blind, multicenter, placebo-controlled study. Fertil Steril 108:673–678CrossRef Osuga Y, Fujimoto-Okabe H, Hagino A (2017) Evaluation of the efficacy and safety of dienogest in the treatment of painful symptoms in patients with adenomyosis: a randomized, double-blind, multicenter, placebo-controlled study. Fertil Steril 108:673–678CrossRef
32.
Zurück zum Zitat Ota Y, Andou M, Yanai S, Nakajima S, Fukada M, Takano M et al (2015) Long-term administration of dienogest reduces recurrence after excision of endometrioma. J Endometr Pelvic Pain Disord 7:63–67 Ota Y, Andou M, Yanai S, Nakajima S, Fukada M, Takano M et al (2015) Long-term administration of dienogest reduces recurrence after excision of endometrioma. J Endometr Pelvic Pain Disord 7:63–67
33.
Zurück zum Zitat Practice Committee of the American Society for Reproductive Medicine (2014) Treatment of pelvic pain associated with endometriosis: a committee opinion. Fertil Steril 101:927–935CrossRef Practice Committee of the American Society for Reproductive Medicine (2014) Treatment of pelvic pain associated with endometriosis: a committee opinion. Fertil Steril 101:927–935CrossRef
34.
Zurück zum Zitat Römer T, Pütz A (1999) Der Teufelskreis der Endometriose. Zentralbl Gynakol 121:305–311 Römer T, Pütz A (1999) Der Teufelskreis der Endometriose. Zentralbl Gynakol 121:305–311
35.
Zurück zum Zitat Römer T (2012) Therapie der Endometriose. Med Monatsschr Pharm 35:44–51 Römer T (2012) Therapie der Endometriose. Med Monatsschr Pharm 35:44–51
36.
Zurück zum Zitat Römer T (2018) Long-term treatment of endometriosis with dienogest: retrospective analysis of efficacy and safety in clinical practice. Arch Gynecol Obstet 298:747–753CrossRef Römer T (2018) Long-term treatment of endometriosis with dienogest: retrospective analysis of efficacy and safety in clinical practice. Arch Gynecol Obstet 298:747–753CrossRef
37.
Zurück zum Zitat Saridogan E (2017) Adolescent endometriosis. Eur J Obstet Gynecol Reprod Biol 209:46–49CrossRef Saridogan E (2017) Adolescent endometriosis. Eur J Obstet Gynecol Reprod Biol 209:46–49CrossRef
38.
Zurück zum Zitat Saunders PTK, Horne AW (2021) Endometriosis: etiology, pathobiology, and therapeutic prospects. Cell 184:2807–2824CrossRef Saunders PTK, Horne AW (2021) Endometriosis: etiology, pathobiology, and therapeutic prospects. Cell 184:2807–2824CrossRef
39.
Zurück zum Zitat Schweppe K‑W (2010) Different progestins in the treatment of endometriosis—are there relevant differences? Horm Mol Biol Clin Investig 3:473–475 Schweppe K‑W (2010) Different progestins in the treatment of endometriosis—are there relevant differences? Horm Mol Biol Clin Investig 3:473–475
40.
Zurück zum Zitat Strowitzki T, Faustmann T, Gerlinger C, Schumacher U, Ahlers C, Seitz C (2015) Safety and tolerability of dienogest in endometriosis. Pooled analysis from the European clinical study program. Int J Womens Health 7:393–401CrossRef Strowitzki T, Faustmann T, Gerlinger C, Schumacher U, Ahlers C, Seitz C (2015) Safety and tolerability of dienogest in endometriosis. Pooled analysis from the European clinical study program. Int J Womens Health 7:393–401CrossRef
41.
Zurück zum Zitat Strowitzki T, Marr J, Gerlinger C, Faustmann T, Seitz C (2012) Detailed analysis of a randomized, multicenter, comparative trial of dienogest versus leuprolide acetate in endometriosis. Int J Gynaecol Obstet 117:228–233CrossRef Strowitzki T, Marr J, Gerlinger C, Faustmann T, Seitz C (2012) Detailed analysis of a randomized, multicenter, comparative trial of dienogest versus leuprolide acetate in endometriosis. Int J Gynaecol Obstet 117:228–233CrossRef
42.
Zurück zum Zitat Strowitzki T, Faustmann T, Gerlinger C, Seitz C (2010) Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study. Eur J Obstet Gynecol Reprod Biol 151:193–198CrossRef Strowitzki T, Faustmann T, Gerlinger C, Seitz C (2010) Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study. Eur J Obstet Gynecol Reprod Biol 151:193–198CrossRef
43.
Zurück zum Zitat Taylor HS, Dun EC, Chwalisz K (2019) Clinical evaluation of the oral gonadotropin-releasing hormone-antagonist elagolix for the management of endometriosis-associated pain. Pain Manag 9:497–515CrossRef Taylor HS, Dun EC, Chwalisz K (2019) Clinical evaluation of the oral gonadotropin-releasing hormone-antagonist elagolix for the management of endometriosis-associated pain. Pain Manag 9:497–515CrossRef
44.
Zurück zum Zitat Vannuccini S, Clemenza S, Rossi M, Petraglia F (2002) Hormonal treatments for endometriosis: the endocrine background. Rev Endocr Metab Disord 23:333–355CrossRef Vannuccini S, Clemenza S, Rossi M, Petraglia F (2002) Hormonal treatments for endometriosis: the endocrine background. Rev Endocr Metab Disord 23:333–355CrossRef
45.
Zurück zum Zitat Vercellini P, Crosignani PG, Fadini R, Radici E, Belloni C, Sismondi P (1999) A gonadothrophin-releasing hormone agonist compared with expectant management after conservative surgery for symptomatic endometriosis. Br J Obstet Gynaecol 106:672–677CrossRef Vercellini P, Crosignani PG, Fadini R, Radici E, Belloni C, Sismondi P (1999) A gonadothrophin-releasing hormone agonist compared with expectant management after conservative surgery for symptomatic endometriosis. Br J Obstet Gynaecol 106:672–677CrossRef
46.
Zurück zum Zitat Vercellini P, Eskenazi B, Consonni D, Somigliana E, Parazzini F, Abbiati A et al (2011) Oral contraceptives and risk of endometriosis: a systematic review and meta-analysis. Hum Reprod Update 17:159–170CrossRef Vercellini P, Eskenazi B, Consonni D, Somigliana E, Parazzini F, Abbiati A et al (2011) Oral contraceptives and risk of endometriosis: a systematic review and meta-analysis. Hum Reprod Update 17:159–170CrossRef
47.
Zurück zum Zitat Vercellini P, Frattaruolo MP, Rosati R, Dridi D, Roberto A, Mosconi P et al (2018) Medical treatment of surgery for colorectal endometriosis? Results of a shared decision-making approach. Hum Reprod 33:202–211CrossRef Vercellini P, Frattaruolo MP, Rosati R, Dridi D, Roberto A, Mosconi P et al (2018) Medical treatment of surgery for colorectal endometriosis? Results of a shared decision-making approach. Hum Reprod 33:202–211CrossRef
48.
Zurück zum Zitat Vlahos N, Vlachos A, Triantafyllidou O, Vitoratos N, Creatsas G (2013) Continuous versus cyclic use of oral contraceptives after surgery for symptomatic endometriosis: a prospective study. Fertil Steril 100:1337–1342CrossRef Vlahos N, Vlachos A, Triantafyllidou O, Vitoratos N, Creatsas G (2013) Continuous versus cyclic use of oral contraceptives after surgery for symptomatic endometriosis: a prospective study. Fertil Steril 100:1337–1342CrossRef
49.
Zurück zum Zitat Zakhari A, Delpero E, McKeown S, Tomlinson G, Bougie O, Murji A (2021) Endometriosis recurrence following post-operative hormonal suppression: a systematic review and meta-analysis. Hum Reprod Update 27(1):96–107CrossRef Zakhari A, Delpero E, McKeown S, Tomlinson G, Bougie O, Murji A (2021) Endometriosis recurrence following post-operative hormonal suppression: a systematic review and meta-analysis. Hum Reprod Update 27(1):96–107CrossRef
50.
Zurück zum Zitat Brown J, Crawford TJ, Allen C, Hopewell S, Prentice A (2017) Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis. Cochrane Database Syst Rev 1:CD4753 Brown J, Crawford TJ, Allen C, Hopewell S, Prentice A (2017) Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis. Cochrane Database Syst Rev 1:CD4753
Metadaten
Titel
Medikamentöse Therapie der Endometriose – ein Update
verfasst von
Prof. Dr. med. Thomas Römer
Publikationsdatum
09.11.2022
Verlag
Springer Vienna
Erschienen in
Journal für Gynäkologische Endokrinologie/Schweiz / Ausgabe 4/2022
Print ISSN: 1995-6924
Elektronische ISSN: 2520-8500
DOI
https://doi.org/10.1007/s41975-022-00268-6

Weitere Artikel der Ausgabe 4/2022

Journal für Gynäkologische Endokrinologie/Schweiz 4/2022 Zur Ausgabe

Editorial

Editorial